Dalfopristin is a semi-synthetic streptogramin antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It is indicated for the treatment of complicated skin and skin… Read more
Dalfopristin is a semi-synthetic streptogramin antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It is indicated for the treatment of complicated skin and skin structure infections, particularly those caused by resistant organisms such as methicillin-resistant Staphylococcus aureus. In pharmaceutical research and manufacturing, high-quality reference standards of Dalfopristin, as well as its related impurities, metabolites, and stable isotope-labelled compounds, are essential for rigorous quality control and method validation. These compounds are critical for accurate impurity profiling and quantitative analysis throughout the drug development lifecycle. By facilitating precise monitoring of synthetic by-products and degradation products, these materials support laboratories in maintaining compliance with regulatory standards for pharmaceutical testing. This collection also includes standards related to the co-administration of Quinupristin and Dalfopristin, ensuring comprehensive analytical support for this class of antibacterial agents.